We are live on
!
Find out more
OASM
Oasmia Pharmaceutical AB
OASM
OASM
Delisted
OASM was delisted on the 21st of August, 2019.
4 hedge funds and large institutions have $212K invested in Oasmia Pharmaceutical AB in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
88% more capital invested
Capital invested by funds: $113K → $212K (+$99K)
20% less funds holding
Funds holding: 5 → 4 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$69.7K |
| 2 |
VF
Virtu Financial
New York
|
+$24.1K |
| 3 |
Morgan Stanley
New York
|
+$5.06K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.99K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$54K |
| 2 |
Jane Street
New York
|
-$37K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$21K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CLOS
1
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| $141K | +$69.7K | +33,300 | New |
|
|
VF
2
Virtu Financial
New York
| $49K | +$24.1K | +11,517 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $12K | +$3.99K | +1,905 | +224% |
|
|
4
Morgan Stanley
New York
| $10K | +$5.06K | +2,419 | +241,900% |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$54K | -40,801 | Closed |
|
|
6
Jane Street
New York
| – | -$37K | -26,771 | Closed |
|
|
OMC
7
Old Mission Capital
Chicago,
Illinois
| – | -$21K | -16,147 | Closed |
|